Chester County News and Community Website
MALVERN, PA — Unite for HER is expanding a national breast cancer support program with TOUCH, The Black Breast Cancer Alliance, to provide free patient services aimed at reducing treatment-related …
Unite for HER Expands Breast Cancer Support for Black Women Read More
HARRISBURG, PA — Pennsylvania lawmakers have introduced legislation that would require healthcare providers to receive education about inflammatory breast cancer, an aggressive form of the disease that can be mistaken …
Pennsylvania Bill Targets Delayed Breast Cancer Diagnoses Read More
WILMINGTON, DE — Prelude Therapeutics Inc. (Nasdaq: PRLD) has entered a clinical trial collaboration with Eli Lilly and Co. to evaluate an experimental breast cancer treatment alongside two Lilly drugs, …
Prelude Partners With Lilly to Test Breast Cancer Drug Combinations Read More
WEST CHESTER, PA — Hundreds of dancers, families and community members will come together in West Chester for an evening of performances, heartfelt tributes and support for people affected by …
ICYMI: West Chester Dancers Unite for Cancer Patients at Dance for HER Read More
EXTON, PA — Dance Society, a new adult dance and fitness studio in Exton, will celebrate its official Grand Opening on Saturday, October 3, from 9:00 to 11:30 a.m., with …
Dance Society to Celebrate Grand Opening with Community Fundraiser Benefiting Unite for HER Read More WILMINGTON, DE — Prelude Therapeutics Inc. (Nasdaq: PRLD) received U.S. Food and Drug Administration clearance to begin a Phase 1 trial of PRT13722, moving its experimental KAT6A-targeting breast cancer drug …
Prelude Wins FDA Clearance to Move Breast Cancer Drug to Trial Read More
WILMINGTON, DE — AstraZeneca’s (NYSE: AZN) ETCAMAH (camizestrant) combination won accelerated U.S. approval for certain advanced breast cancer patients whose tumors develop an ESR1 mutation during first-line therapy, allowing treatment …
FDA Clears AstraZeneca Breast Cancer Regimen on Early Detection Read More WILMINGTON, DE — AstraZeneca reported updated Phase III trial results showing its investigational breast cancer therapy camizestrant extended the time patients lived without disease progression and delayed the need for …
AstraZeneca Breast Cancer Drug Extends Progression-Free Survival Read More
WILMINGTON, DE — AstraZeneca and Daiichi Sankyo have secured U.S. approval for DATROWAY as a first-line treatment for certain patients with metastatic triple-negative breast cancer, expanding treatment options in a …
AstraZeneca, Daiichi Sankyo Win FDA Approval for DATROWAY in Breast Cancer Read More
PHILADELPHIA, PA — Susan G. Komen plans to raise a combined $725,000 through breast cancer fundraising walks in Philadelphia and Pittsburgh this month as cancer advocacy groups face growing demand …
Susan G. Komen Expands Pennsylvania Fundraising Effort Read More